The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Heart Failure Drugs Market Research Report 2024
Synopsis
Heart failure occurs when your heart muscle doesn't pump blood as well as it should.
The global Heart Failure Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
Report Scope
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Heart failure occurs when your heart muscle doesn't pump blood as well as it should.
The global Heart Failure Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market is concentrated as Novartis, Pfizer, AstraZeneca , Hikma, Teva etc. Turkey is the largest consumption place in the Turkey and Middle East & Africa market, with a consumption market share nearly 21%.
This report aims to provide a comprehensive presentation of the global market for Heart Failure Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heart Failure Drugs.
Report Scope
The Heart Failure Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heart Failure Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heart Failure Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Pfizer
AstraZeneca
Hikma
Teva
Cipla
Merck & Co.
Amgen
Roche
Sun Pharma
Mylan
Segment by Type
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
Segment by Application
Reduced Ejection Fraction
Preserved Ejection Fraction
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heart Failure Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heart Failure Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Heart Failure Drugs Market Overview
1.1 Product Overview and Scope of Heart Failure Drugs
1.2 Heart Failure Drugs Segment by Type
1.2.1 Global Heart Failure Drugs Market Value Comparison by Type (2024-2030)
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Heart Failure Drugs Segment by Application
1.3.1 Global Heart Failure Drugs Market Value by Application: (2024-2030)
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Global Heart Failure Drugs Market Size Estimates and Forecasts
1.4.1 Global Heart Failure Drugs Revenue 2019-2030
1.4.2 Global Heart Failure Drugs Sales 2019-2030
1.4.3 Global Heart Failure Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Heart Failure Drugs Market Competition by Manufacturers
2.1 Global Heart Failure Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Heart Failure Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Heart Failure Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Heart Failure Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heart Failure Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heart Failure Drugs, Product Type & Application
2.7 Heart Failure Drugs Market Competitive Situation and Trends
2.7.1 Heart Failure Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Heart Failure Drugs Players Market Share by Revenue
2.7.3 Global Heart Failure Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Heart Failure Drugs Retrospective Market Scenario by Region
3.1 Global Heart Failure Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Heart Failure Drugs Global Heart Failure Drugs Sales by Region: 2019-2030
3.2.1 Global Heart Failure Drugs Sales by Region: 2019-2024
3.2.2 Global Heart Failure Drugs Sales by Region: 2025-2030
3.3 Global Heart Failure Drugs Global Heart Failure Drugs Revenue by Region: 2019-2030
3.3.1 Global Heart Failure Drugs Revenue by Region: 2019-2024
3.3.2 Global Heart Failure Drugs Revenue by Region: 2025-2030
3.4 North America Heart Failure Drugs Market Facts & Figures by Country
3.4.1 North America Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Heart Failure Drugs Sales by Country (2019-2030)
3.4.3 North America Heart Failure Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heart Failure Drugs Market Facts & Figures by Country
3.5.1 Europe Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Heart Failure Drugs Sales by Country (2019-2030)
3.5.3 Europe Heart Failure Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heart Failure Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Heart Failure Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Heart Failure Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heart Failure Drugs Market Facts & Figures by Country
3.7.1 Latin America Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Heart Failure Drugs Sales by Country (2019-2030)
3.7.3 Latin America Heart Failure Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heart Failure Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Heart Failure Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Heart Failure Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Heart Failure Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Heart Failure Drugs Sales by Type (2019-2030)
4.1.1 Global Heart Failure Drugs Sales by Type (2019-2024)
4.1.2 Global Heart Failure Drugs Sales by Type (2025-2030)
4.1.3 Global Heart Failure Drugs Sales Market Share by Type (2019-2030)
4.2 Global Heart Failure Drugs Revenue by Type (2019-2030)
4.2.1 Global Heart Failure Drugs Revenue by Type (2019-2024)
4.2.2 Global Heart Failure Drugs Revenue by Type (2025-2030)
4.2.3 Global Heart Failure Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Heart Failure Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Heart Failure Drugs Sales by Application (2019-2030)
5.1.1 Global Heart Failure Drugs Sales by Application (2019-2024)
5.1.2 Global Heart Failure Drugs Sales by Application (2025-2030)
5.1.3 Global Heart Failure Drugs Sales Market Share by Application (2019-2030)
5.2 Global Heart Failure Drugs Revenue by Application (2019-2030)
5.2.1 Global Heart Failure Drugs Revenue by Application (2019-2024)
5.2.2 Global Heart Failure Drugs Revenue by Application (2025-2030)
5.2.3 Global Heart Failure Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Heart Failure Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Heart Failure Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Heart Failure Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca Heart Failure Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Hikma
6.4.1 Hikma Corporation Information
6.4.2 Hikma Description and Business Overview
6.4.3 Hikma Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Heart Failure Drugs Product Portfolio
6.4.5 Hikma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Heart Failure Drugs Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Heart Failure Drugs Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Merck & Co.
6.6.1 Merck & Co. Corporation Information
6.6.2 Merck & Co. Description and Business Overview
6.6.3 Merck & Co. Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co. Heart Failure Drugs Product Portfolio
6.7.5 Merck & Co. Recent Developments/Updates
6.8 Amgen
6.8.1 Amgen Corporation Information
6.8.2 Amgen Description and Business Overview
6.8.3 Amgen Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Amgen Heart Failure Drugs Product Portfolio
6.8.5 Amgen Recent Developments/Updates
6.9 Roche
6.9.1 Roche Corporation Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Roche Heart Failure Drugs Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Sun Pharma
6.10.1 Sun Pharma Corporation Information
6.10.2 Sun Pharma Description and Business Overview
6.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Pharma Heart Failure Drugs Product Portfolio
6.10.5 Sun Pharma Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Heart Failure Drugs Description and Business Overview
6.11.3 Mylan Heart Failure Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mylan Heart Failure Drugs Product Portfolio
6.11.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heart Failure Drugs Industry Chain Analysis
7.2 Heart Failure Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heart Failure Drugs Production Mode & Process
7.4 Heart Failure Drugs Sales and Marketing
7.4.1 Heart Failure Drugs Sales Channels
7.4.2 Heart Failure Drugs Distributors
7.5 Heart Failure Drugs Customers
8 Heart Failure Drugs Market Dynamics
8.1 Heart Failure Drugs Industry Trends
8.2 Heart Failure Drugs Market Drivers
8.3 Heart Failure Drugs Market Challenges
8.4 Heart Failure Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
